Davy James, Associate Editor

Delivery system kills chemotherapy-resistant cancer stem cells and prevents secondary tumor formation.

Expanded use includes patients newly diagnosed with the disease.

Celgene today announced that the FDA has granted an expanded use approval for its multiple myeloma drug, lenalidomide (Revlimid).

Experimental device offers non-invasive method to diagnose disease.

Multiple strains of HIV recombine into new variant.

Activation of protein causes cells to change shape and become motile.

Genetic variants found that are associated with psoriatic arthritis, but not psoriasis.

Enzyme associated with metabolic programming may lead to new treatments.

Researchers examine the potential of creating new eggs with stem cells.

Study examines how side effects from commonly used antibiotics effect mitochondria of cancer cells.

Mosquito-borne virus causes joint pain and swelling similar to rheumatoid arthritis.

Diabetics who took metformin saw a decreased chance of developing adenocarcinoma.

Scientists map pathological progress of disease.

Spontaneous cure achieved in first person documented with WHIM Syndrome.

Annual rate of primary tumor removal has decreased since 1988.

Cells found to hijack vitamin D receptors to repair damage caused by therapy.

Diplomat Pharmacy, Inc, serves patients in all 50 states with a focus on medication management programs tailored to the treatment of complex chronic disease states.

Trend reflects growing tobacco epidemic among women.

Biological process may lead to failure of embryo to attach to uterine wall.

Efficacy and safety demonstrated in models of aggressive leukemia.

Genomic sequencing reveals effect of hepatitis on genetic mutations in tumors.

Entry of web site into particular market correlates with increase in new cases.

A recent study has identified how chronic hepatitis infection can pave the way to liver cancer.

Death risk twice as high for survivors who smoke compared with non-smokers.

Phase 3 trial for polycythemia vera drug significantly improved hematocrit control without the need for phlebotomy.

Progression-free survival improved from treatment during phase 3 trial.

Palbociclib inhibits molecules that promote cancer cell growth.

Research identifies how tumors resist current treatments.

Treatment was previously designated as a breakthrough therapy for bladder cancer.

The FDA today granted accelerated approval to a drug that treats breast cancer in postmenopausal women by attacking molecules that promote cancer cell growth.